Evaluation of Trastuzumab Anti-Tumor Efficacy and its Correlation with HER-2 Status in Patient-Derived Gastric Adenocarcinoma Xenograft Models.

MLA

Chen, Hao, et al. “Evaluation of Trastuzumab Anti-Tumor Efficacy and Its Correlation with HER-2 Status in Patient-Derived Gastric Adenocarcinoma Xenograft Models.” Pathology Oncology Research : POR, vol. 21, no. 4, Sept. 2015, pp. 947–55. EBSCOhost, https://doi.org/10.1007/s12253-015-9909-8.

APA

Chen, H., Ye, Q., Lv, J., Ye, P., Sun, Y., Fan, S., Su, X., Gavine, P., & Yin, X. (2015). Evaluation of Trastuzumab Anti-Tumor Efficacy and its Correlation with HER-2 Status in Patient-Derived Gastric Adenocarcinoma Xenograft Models. Pathology Oncology Research : POR, 21(4), 947–955. https://doi.org/10.1007/s12253-015-9909-8

Chicago

Chen, Hao, Qingqing Ye, Jing Lv, Peng Ye, Yun Sun, Shuqiong Fan, Xinying Su, Paul Gavine, and Xiaolu Yin. 2015. “Evaluation of Trastuzumab Anti-Tumor Efficacy and Its Correlation with HER-2 Status in Patient-Derived Gastric Adenocarcinoma Xenograft Models.” Pathology Oncology Research : POR 21 (4): 947–55. doi:10.1007/s12253-015-9909-8.